The FDA recently mandated that all manufacturers of a class of anti-depressant drugs called Selective Seratonin Reuptake Inhibitors (SSRI’s) to include warnings of suicide and suicide ideation on their labels. Well known SSRI’s include Paxil, Prozac, Zoloft, Wellbutrin and Effexor.
Not only are these drugs linked to an increased suicide risk, but “off-label” use is widespread meaning that the drugs are prescribed to treat more than just depression. The result is millions of people are prescribed the drug and unnecessarily put at risk for increased suicide and suicide attempt.
The risks have been known for years, but once again we are seeing drug companies misleading the FDA and concealing studies indicating serious risks. The risk of suicide is especially high within 2-3 weeks after going on the anti-depressant or immediately after stopping the medication. Anyone currently on these medications should work very closely with their doctor to minimize side effects.